Pharmacogenomics in pregnancy

Hannah K. Betcher, Alfred L. George*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Pregnant women frequently take prescription and over the counter medications. The efficacy of medications is affected by the many physiological changes during pregnancy, and these events may be further impacted by genetic factors. Research on pharmacogenomic and pharmacokinetic influences on drug disposition during pregnancy has lagged behind other fields. Clinical investigators have demonstrated altered activity of several drug metabolizing enzymes during pregnancy. Emerging evidence also supports the influence of pharmacogenomic variability in drug response for many important classes of drugs commonly used in pregnancy. Prescribing medications during pregnancy requires an understanding of the substantial dynamic physiologic and metabolic changes that occur during gestation. Pharmacogenomics also contributes to the inter-individual variability in response to many medications, and more research is needed to understand how best to manage drug therapy in pregnant women.

Original languageEnglish (US)
Article number151222
JournalSeminars in Perinatology
Issue number3
StatePublished - Apr 2020


  • Drug metabolism
  • Drug therapy
  • Pharmacogenetics
  • Pharmacogenomics
  • Pregnancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology


Dive into the research topics of 'Pharmacogenomics in pregnancy'. Together they form a unique fingerprint.

Cite this